Skip to main content
Nuvation Bio Inc. (NUVB)
NYSE: NUVB · Real-Time Price · USD
4.730
+0.140 (3.05%)
At close: Mar 9, 2026, 4:00 PM EDT
4.858
+0.128 (2.70%)
After-hours: Mar 9, 2026, 4:37 PM EDT

Nuvation Bio Revenue

In the year 2025, Nuvation Bio had annual revenue of $62.90M with 698.96% growth. Nuvation Bio had revenue of $41.87M in the quarter ending December 31, 2025, with 633.06% growth.

Revenue (ttm)
$62.90M
Revenue Growth
+698.96%
P/S Ratio
25.83
Revenue / Employee
$216,158
Employees
291
Market Cap
1.62B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202562.90M55.03M698.96%
Dec 31, 20247.87M--
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Novavax 1.12B
AnaptysBio 234.60M
Nurix Therapeutics 83.98M
Vir Biotechnology 68.56M
Intellia Therapeutics 67.67M
Agios Pharmaceuticals 54.03M
Nanobiotix 11.93M
Oculis Holding AG 1.51M
Revenue Rankings

NUVB News

More News